Masitinib Impresses in ' Nonactive ' Progressive MS Masitinib Impresses in ' Nonactive ' Progressive MS

The drug, with a completely new mechanism of action for multiple sclerosis, slowed disability in nonactive primary and secondary progressive forms of the disease, where there is no current treatment.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news